查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786454

DNA合成器的全球市场

DNA Synthesizer
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 221 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球 DNA 合成器市场规模将达到 7.878 亿美元

全球DNA合成器市场规模预计在2024年为3.225亿美元，到2030年将达到7.878亿美元，在2024-2030年的分析期间内，复合年增长率为16.1%。桌上型DNA合成器是本报告分析的细分市场之一，预计其复合年增长率为17.9%，到分析期结束时市场规模将达到5.498亿美元。大型DNA合成器细分市场在分析期间的复合年增长率预计为12.5%。

美国市场规模估计为 8,480 万美元，中国市场预计复合年增长率为 15.0%

美国DNA合成器市场规模预计在2024年达到8,480万美元。作为世界第二大经济体，中国市场规模预计将在2030年达到1.211亿美元，2024年至2030年的复合年增长率为15.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为15.0%和13.7%。在欧洲，德国的复合年增长率预计将达到11.6%。

全球 DNA 合成器市场 - 主要趋势与驱动因素摘要

合成 DNA 会成为下一波生技创新的动力吗？

对合成DNA日益增长的需求正在推动生物技术的模式转移，而DNA合成仪正是这项转变的核心。 DNA合成仪能够自动组装客製化DNA序列，已成为研究、诊断、治疗和工业生物技术的重要工具。随着合成生物学的发展，科学家正在利用合成DNA设计基因迴路、创造新生物，并从零开始建构整个基因组。快速高精度地生产寡核苷酸和基因片段的能力正在加速CRISPR基因编辑、mRNA疗法、疫苗开发、代谢工程等领域的研究。例如，在新冠疫情期间，研究人员利用合成仪快速建构病毒基因原型以生产抗原，凸显了合成DNA在疫苗开发中的价值。此外，随着DNA合成成本的持续下降，越来越多的研究机构和生技新兴企业正在将合成仪纳入其实验室，以降低外包成本并缩短计划週转时间。学术机构、製药公司和委外研发机构(CRO) 越来越依赖内部合成能力，以实现更灵活、高通量的工作流程。 DNA 合成仪如今正推动从单基因合成向大规模 DNA 製造的转变，用于基因组组装、基因文库和基于 DNA 的数据存储实验。几乎所有生命科学领域对合成 DNA 的需求都在不断增长，这使得 DNA 合成仪成为推动未来研究、创新和生物製造发展的策略性技术。

技术进步如何提高 DNA 合成的速度、精确度和规模？

近年来，DNA合成技术取得了显着进步，这得益于旨在提高速度、准确性、产量和可扩展性的创新。传统的基于亚磷酰胺的固相合成长期以来一直是短寡核苷酸的黄金标准，但它在序列长度和错误累积方面有其限制。为了克服这些障碍，酵素DNA合成等新技术应运而生。这些方法利用工程聚合酵素和无模板反应，在较温和的水性条件下合成更长、更准确的DNA链。此外，基于微阵列的合成平台如今能够在单一晶片上并行产生数千个DNA序列，从而降低成本并支援基因文库和筛检分析等大规模应用。与机器人技术和自动化技术的结合使DNA合成器更易于使用，能够以最少的人工干预实现无人值守的合成。即时监控系统和先进的品管工具（例如质谱和毛细管电泳）正在整合到下一代合成器中，以确保产品的纯度和产量。人工智慧和机器学习演算法也被用于即时预测合成误差并优化通讯协定，从而提高可重复性和客製化程度。这些技术创新正在将DNA合成的范围从标准实验室应用扩展到临床研究、精准医疗和工业规模生产。现代DNA合成仪不断突破合成工程的界限，在重塑基因组学的发展速度和可能性方面发挥关键作用。

不断扩大的最终用户群是否会重塑 DNA 合成器市场的商业策略？

DNA合成仪市场以终端用户群的多元化为特点，这迫使製造商定制其技术和服务，以满足不同程度的专业技能、应用重点和吞吐量需求。学术机构和核心实验室仍然是主要用户，他们利用合成仪进行基础遗传和细胞生物学研究。然而，製药公司、诊断公司和合成生物学新兴企业的采用率正在迅速增长，这些公司需要大规模、特定应用的DNA合成，以用于临床试验、治疗方法开发和产品创新。活跃于农业、工业酵素和生质燃料领域的公司也正在使用DNA合成仪来优化基因改造作物（GMO）和微生物生产系统。人们对DNA资料储存日益增长的兴趣催生了一个利基市场，即专门用于将数位资料编码到DNA链中的高容量合成仪。随着需求的多样化，商业策略也不断发展。製造商现在为低吞吐量实验室提供桌上型合成仪，为工业用户提供高容量平台，并为希望在不拥有实体设备的情况下存取资料的机构提供云端基础的合成即服务模式。这些服务模式尤其受到新兴企业和学术研究人员的青睐，他们寻求以经济高效的方式获取高品质DNA，而无需投入大量资金。此外，培训计画、软体整合和按需支援正成为商业性服务的重要组成部分，使各层级的使用者都能有效地操作和维护合成仪。透过调整技术以适应不同使用者群体的需求，企业正在巩固其市场地位，并促进生命科学领域内部DNA合成应用的扩展。

推动全球 DNA 合成机器需求的主要市场驱动因素是什么？

DNA合成仪市场的成长受到多种相互关联的因素所驱动，这些因素根植于技术创新、应用扩展和不断变化的用户需求。其中一个关键驱动因素是合成生物学在治疗、农业和生物製造等领域的日益普及，在这些领域，合成DNA是设计生物系统和客製化生物体的基础。疫苗开发中对快速原型製作的需求，尤其是基于mRNA和DNA的平台，也刺激了高通量DNA合成仪的投资。此外，CRISPR和基因编辑研究领域的不断扩展，推动了对精准设计的嚮导RNA和供体模板的需求，从而进一步推动了合成仪的利用率。另一个成长要素是对分散式内部DNA合成解决方案的需求，这些解决方案可以减少对外包的依赖并加快计划进度，尤其是在快节奏的生物技术环境中。自动化合成仪越来越多地融入实验室工作流程，再加上经济高效的耗材的开发，使得中型实验室和新兴企业更容易获得DNA合成。有利于个人化医疗和精准诊断的监管趋势也刺激了能够生产用于靶向检测开发和临床研究的 DNA 的合成仪的开发。此外，合成仪製造商、学术机构和製药公司之间的策略联盟正在加速产品创新和分销。基于酶和晶片的系统等下一代合成技术的出现正在提高永续性、精确度和扩充性，开闢了新的商业性途径。最后，人们对生物技术教育和人才发展的兴趣日益浓厚，正在创造对学术合成仪和培训套件的需求，确保长期的市场扩张。因此，DNA 合成仪被定位为支持基因组科学和生物工程下一个前沿的基础技术。

部分

类型（桌上型 DNA 合成仪、大型 DNA 合成仪）、应用（药物发现和研发、基因工程、临床诊断）、最终用途（学术和研究机构最终用途、製药和生物技术公司最终用途、临床实验室最终用途）

受访公司范例

  • Agilent Technologies, Inc.
  • Applied Biosystems（Thermo Fisher Scientific）
  • ATDBio Ltd.
  • ATG：biosynthetics GmbH
  • ATUM
  • Azenta Life Sciences
  • BaseClear BV
  • BioAutomation Corporation
  • Biolegio BV
  • Biosearch Technologies（LGC Group）
  • Bioneer Corporation
  • Biotage AB
  • Biosynthesis, Inc.
  • CSBio Company, Inc.
  • DNA Script
  • Eurofins Genomics
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.（IDT）
  • Kilobaser GmbH
  • LGC Biosearch Technologies

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP30560

Global DNA Synthesizer Market to Reach US$787.8 Million by 2030

The global market for DNA Synthesizer estimated at US$322.5 Million in the year 2024, is expected to reach US$787.8 Million by 2030, growing at a CAGR of 16.1% over the analysis period 2024-2030. Benchtop DNA Synthesizers, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$549.8 Million by the end of the analysis period. Growth in the Large-scale DNA Synthesizers segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$84.8 Million While China is Forecast to Grow at 15.0% CAGR

The DNA Synthesizer market in the U.S. is estimated at US$84.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$121.1 Million by the year 2030 trailing a CAGR of 15.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.0% and 13.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.6% CAGR.

Global DNA Synthesizer Market - Key Trends & Drivers Summarized

Is Synthetic DNA the Fuel Behind the Next Wave of Biotech Innovation?

The rising demand for synthetic DNA is driving a paradigm shift across the biotechnology landscape, with DNA synthesizers positioned at the heart of this transformation. DNA synthesizers, which enable the automated assembly of custom DNA sequences, have become indispensable tools for research, diagnostics, therapeutics, and industrial biotechnology. As synthetic biology gains momentum, scientists are using synthesized DNA to design gene circuits, create novel organisms, and build entire genomes from scratch. The ability to rapidly produce oligonucleotides and gene fragments with high accuracy is accelerating research in CRISPR gene editing, mRNA therapeutics, vaccine development, and metabolic engineering. COVID-19, for example, underscored the value of synthetic DNA in vaccine development, as researchers leveraged synthesizers to quickly prototype viral genes for antigen production. Furthermore, as the cost of DNA synthesis continues to decline, more institutions and biotech startups are integrating synthesizers into their labs to reduce outsourcing costs and enhance project turnaround times. Academic institutions, pharmaceutical companies, and contract research organizations (CROs) are increasingly relying on in-house synthesis capabilities for more flexible and high-throughput workflows. DNA synthesizers are now enabling a shift from single-gene synthesis to large-scale DNA manufacturing for genome assembly, gene libraries, and DNA-based data storage experiments. This growing demand for synthetic DNA in nearly every domain of life sciences positions DNA synthesizers as a strategic technology driving the future of research, innovation, and biomanufacturing.

How Are Technological Advancements Enhancing DNA Synthesis Speed, Accuracy, and Scale?

DNA synthesizer technologies have advanced significantly in recent years, with innovations aimed at improving speed, accuracy, yield, and scalability. Traditional phosphoramidite-based solid-phase synthesis has long been the gold standard for short oligonucleotides, but it faces limitations in sequence length and error accumulation. To overcome these barriers, emerging techniques such as enzymatic DNA synthesis are gaining attention. These methods use engineered polymerases and template-free reactions to synthesize longer and more accurate DNA strands under milder, aqueous conditions-offering potential breakthroughs in both sustainability and efficiency. Additionally, microarray-based synthesis platforms now allow parallel production of thousands of DNA sequences on a single chip, reducing costs and supporting large-scale applications like gene libraries and screening assays. Integration with robotics and automation has made DNA synthesizers more user-friendly, enabling walkaway synthesis with minimal human intervention. Real-time monitoring systems and advanced quality control tools-such as mass spectrometry and capillary electrophoresis-are being incorporated into next-generation synthesizers to ensure product purity and yield. AI and machine learning algorithms are also being utilized to predict synthesis errors and optimize protocols in real time, increasing reproducibility and customization. These innovations are expanding the reach of DNA synthesis beyond standard laboratory use to clinical research, precision medicine, and industrial-scale production. By pushing the boundaries of what can be synthetically engineered, modern DNA synthesizers are playing a crucial role in reshaping the pace and potential of genomic science.

Is the Broadening End-User Base Reshaping Commercial Strategies in the DNA Synthesizer Market?

The DNA synthesizer market is experiencing significant diversification in its end-user base, which is prompting manufacturers to tailor their technologies and services to suit varying levels of expertise, application focus, and throughput needs. Academic institutions and core research labs remain key users, utilizing synthesizers for fundamental genetic and cellular biology research. However, the market is witnessing a sharp rise in adoption among pharmaceutical companies, diagnostics firms, and synthetic biology startups that require high-volume, application-specific DNA synthesis for clinical trials, therapeutic development, and product innovation. Companies working in the fields of agriculture, industrial enzymes, and biofuels are also using DNA synthesizers to optimize genetically modified organisms (GMOs) and microbial production systems. The growing interest in DNA data storage is creating a niche segment of high-capacity synthesizers tailored for encoding digital data into DNA strands. As demand diversifies, commercial strategies are evolving: manufacturers now offer benchtop synthesizers for low-throughput labs, high-capacity platforms for industrial users, and cloud-based synthesis-as-a-service models for institutions seeking access without owning physical equipment. These service models are particularly popular among startups and academic researchers looking for cost-effective access to high-quality DNA without large capital expenditure. Additionally, training programs, software integrations, and on-demand support are becoming integral to commercial offerings, ensuring that users of all levels can effectively operate and maintain synthesizers. By aligning technology with the needs of diverse user groups, companies are strengthening their market position and fostering broader adoption of in-house DNA synthesis capabilities across the life sciences spectrum.

What Are the Key Market Drivers Fueling Demand for DNA Synthesizers Globally?

The growth in the DNA synthesizer market is driven by several interlinked factors rooted in technological innovation, expanding applications, and evolving user demands. One of the primary drivers is the rising adoption of synthetic biology in fields such as therapeutics, agriculture, and bio-manufacturing, where synthetic DNA is foundational to designing biological systems and custom organisms. The need for rapid prototyping in vaccine development, especially mRNA and DNA-based platforms, is also fueling investment in high-throughput DNA synthesis equipment. Additionally, the global expansion of CRISPR and gene editing research is driving the need for precision-engineered guide RNAs and donor templates, further boosting synthesizer usage. Another growth factor is the demand for decentralized, in-house DNA synthesis solutions that reduce dependency on outsourcing and accelerate project timelines-especially important in fast-paced biotech environments. The increasing integration of automated synthesizers into lab workflows, coupled with the development of cost-effective consumables, is making DNA synthesis more accessible to mid-sized labs and startups. Regulatory trends favoring personalized medicine and precision diagnostics are also stimulating the development of synthesizers that can produce DNA for targeted assay development and clinical research. Furthermore, strategic collaborations between synthesizer manufacturers, academic institutions, and pharmaceutical companies are accelerating product innovation and distribution. The advent of next-generation synthesis technologies, such as enzymatic and chip-based systems, is opening new commercial avenues with improved sustainability, accuracy, and scalability. Lastly, the growing focus on biotechnology education and workforce development is creating demand for academic synthesizers and training kits, ensuring long-term market expansion. Together, these diverse yet converging drivers are positioning DNA synthesizers as a cornerstone technology powering the next frontier of genomic science and bioengineering.

SCOPE OF STUDY:

The report analyzes the DNA Synthesizer market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Benchtop DNA Synthesizers, Large-scale DNA Synthesizers); Application (Drug Discovery & Development Application, Genetic Engineering Application, Clinical Diagnostics Application); End-Use (Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use, Clinical Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • Applied Biosystems (Thermo Fisher Scientific)
  • ATDBio Ltd.
  • ATG:biosynthetics GmbH
  • ATUM
  • Azenta Life Sciences
  • BaseClear B.V.
  • BioAutomation Corporation
  • Biolegio B.V.
  • Biosearch Technologies (LGC Group)
  • Bioneer Corporation
  • Biotage AB
  • Biosynthesis, Inc.
  • CSBio Company, Inc.
  • DNA Script
  • Eurofins Genomics
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc. (IDT)
  • Kilobaser GmbH
  • LGC Biosearch Technologies

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • DNA Synthesizer - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Boom in Synthetic Biology and Genomic Engineering Throws the Spotlight on Automated DNA Synthesis Platforms
    • Rising Demand for Custom Genes and Oligonucleotides Propels Growth in On-Demand DNA Synthesizer Adoption
    • Declining Cost of DNA Synthesis Strengthens Business Case for In-House Synthesizer Integration
    • Advancements in Enzymatic and Chip-Based Synthesis Methods Accelerate Market Transition from Traditional Chemistries
    • Integration of DNA Synthesizers with Lab Automation Systems Drives Efficiency in High-Throughput Workflows
    • Proliferation of CRISPR and Gene Editing Applications Expands Use of Synthesizers in Research and Therapeutics
    • Growing Role of DNA in Data Storage and Nanotechnology Opens New Commercial Avenues for DNA Synthesizer Technologies
    • Academic and Biotech Startups Turn to Benchtop Synthesizers to Reduce Outsourcing and Speed R&D Cycles
    • Rising Demand for Synthetic Gene Libraries Spurs Need for Scalable, Multiplexed Synthesis Platforms
    • Use of AI for Sequence Optimization Enhances Accuracy, Customization, and Yield of Synthesized DNA
    • Growth in Vaccine Development and mRNA Therapeutics Generates Demand for Rapid and Flexible DNA Synthesis
    • Expansion of Biofoundries and Distributed Manufacturing Models Strengthens Demand for Modular Synthesizer Units
    • Global Investment in Synthetic Genomics Research Sustains Long-Term Growth Opportunities for DNA Synthesizer Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA Synthesizer Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA Synthesizer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DNA Synthesizer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for DNA Synthesizer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Benchtop DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Benchtop DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Benchtop DNA Synthesizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large-scale DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Large-scale DNA Synthesizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Large-scale DNA Synthesizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Genetic Engineering Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Genetic Engineering Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for DNA Synthesizer by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for DNA Synthesizer by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DNA Synthesizer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for DNA Synthesizer by Type - Benchtop DNA Synthesizers and Large-scale DNA Synthesizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for DNA Synthesizer by Type - Percentage Breakdown of Value Sales for Benchtop DNA Synthesizers and Large-scale DNA Synthesizers for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for DNA Synthesizer by Application - Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of World 15-Year Perspective for DNA Synthesizer by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Genetic Engineering Application and Clinical Diagnostics Application for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for DNA Synthesizer by End-Use - Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for DNA Synthesizer by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use and Clinical Laboratories End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION